Search

Author/Creator de la Peña, L

1. DOP17 HIV infection is associated with a less aggressive phenotype of inflammatory bowel disease. A multicenter study based on the ENEIDA registry. (30th January 2023)

Authors:
Calafat Sard, M; Súria, C; Mesonero, F; de Francisco, R; Yagüe Caballero, C; de la Peña, L; Hernández-Camba, A; Marcè, A; Gallego, B; Martín-Vicente, N; Rivero, M; Iborra, M; Guerra, I; Carrillo-Palau, M; Madero, L; Burgueño, B; Montfort, D; Torres, G; Teller, M; Ferrer Rosique, J Á
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i80
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer. (30th May 2019)

Authors:
Oliveira, M; Saura, C; Nuciforo, P; Calvo, I; Andersen, J; Passos-Coelho, J L; Gil Gil, M; Bermejo, B; Patt, D A; Ciruelos, E; de la Peña, L; Xu, N; Wongchenko, M; Shi, Z; Singel, S M; Isakoff, S J
Journal:
Annals of oncology
Issue:
Volume 30:Number 8(2019)
Page Start:
1289
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P386 Clinical presentation, management, and evolution of lymphomas in patients with Inflammatory Bowel Disease: an ENEIDA registry study. (30th January 2023)

Authors:
Guerra Marina, I; Bujanda, L; Mañosa, M; Pérez-Martínez, I; Casanova, M J; de la Peña, L; de Benito, M; Rivero, M; Varela, P; Bernal, L; Franco, A C; Ber, Y; Piqueras, M; Tardillo, C; Ponferrada, Á; Olivares, S; Lucendo, A J; Gilabert, P; Sierra Ausín, M; Bellart, M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i519
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P635 Carriage of the HLA-DQA1*05 allele is associated with a high risk of loss of response to infliximab in patients with inflammatory bowel disease. (25th January 2019)

Authors:
Guardiola, J; Rodriguez Alonso, L; Santacana, E; Padró, A; Serra, K; Padullés, N; Ruiz-Cerulla, A; Gilabert, P; Arajol, C; Ibañez-Sanz, G; Camps, B; Orobitg, J; Serracarbasa, A; de la Peña, L; Berrozpe, A; Rodriguez Moranta, F
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S435
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P778 Effectiveness and safety of a second-line rescue therapy for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study). (30th January 2023)

Authors:
García, M J; Riestra, S; Amiot, A; Julsgaard, M; García de la Filia, I; Calafat, M; Aguas, M; de la Peña, L; Roig-Ramos, C; Caballol, B; Casanova, M J; Farkas, K; Boysen, T; Bujanda, L; Cuarán, C; Dobru, D; Fousekis, F; Gargallo-Puyuelo, C J; Savarino, E; Calvet, X
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i911
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗